business
WellPoint conducts research on comparative effectiveness
NEWS IN BRIEF — Posted Feb. 21, 2011
HealthCore, the research arm of WellPoint, has teamed up with AstraZeneca Pharmaceuticals to conduct comparative effectiveness research on how well medicines and treatments are working in treating chronic illnesses.
The groups will focus on drugs already on the market. Their research will include prospective and retrospective studies on disease and provide insight into new types of therapies needed for treating and preventing disease.
Unlike controlled studies, the research will involve real-world analysis of data found in electronic medical records as well as claims information and patient surveys.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2011/02/21/bibf0221.htm.












